€31.0M
The Dublin-based artificial intelligence startup secured backing from Molten Ventures, ACT Venture Capital, and Seroba to expand its global footprint.
"This investment accelerates our mission to transform global pathology access. Our ergonomic, AI-enabled platform enhances diagnostic workflow and accuracy – allowing experts to clear backlogs faster without compromising quality. By expanding this technology worldwide, we’re not just improving healthcare efficiency, we’re supporting both the pathologists who drive diagnoses and the patients who depend on them."
